Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage
Open Access
- 19 August 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (16) , 4038
Abstract
Osteoporosis is a common disorder of bone remodeling, caused by the imbalance between bone resorption by osteoclasts and bone formation by osteoblasts. Recently, we reported that matrix metalloproteinase-9 (MMP-9)-dependent histone H3 proteolysis is a key event for proficient osteoclast formation. Although it has been reported that several MMP-9 inhibitors, such as tetracycline and its derivatives, show an inhibitory effect on osteoclastogenesis, the molecular mechanisms for this are not fully understood. Here we show that tetracycline analogs, especially tigecycline and minocycline, inhibit osteoclast formation by blocking MMP-9-mediated histone H3 tail cleavage. Our molecular docking approach found that tigecycline and minocycline are the most potent inhibitors of MMP-9. We also observed that both inhibitors significantly inhibited H3 tail cleavage by MMP-9 in vitro. These compounds inhibited receptor activator of nuclear factor kappaB ligand (RANKL)-induced osteoclast formation by blocking the NFATc1 signaling pathway. Furthermore, MMP-9-mediated H3 tail cleavage during osteoclast differentiation was selectively blocked by these compounds. Treatment with both tigecycline and minocycline rescued the osteoporotic phenotype induced by prednisolone in a zebrafish osteoporosis model. Our findings demonstrate that the tetracycline analogs suppress osteoclastogenesis via MMP-9-mediated H3 tail cleavage, and suggest that MMP-9 inhibition could offer a new strategy for the treatment of glucocorticoid-induced osteoporosis.Keywords
This publication has 33 references indexed in Scilit:
- Vpr-Binding Protein Antagonizes p53-Mediated Transcription via Direct Interaction with H3 TailMolecular and Cellular Biology, 2012
- The history of the tetracyclinesAnnals of the New York Academy of Sciences, 2011
- Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cellsArchives of Oral Biology, 2011
- Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivoExperimental Cell Research, 2011
- Should bisphosphonates be used for long‐term treatment of glucocorticoid‐induced osteoporosis?Arthritis & Rheumatism, 2010
- Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid ReceptorCell Metabolism, 2010
- Matrix Metalloproteinase InhibitorsDrugs, 2010
- Isolation and Characterization of a Novel H1.2 Complex That Acts as a Repressor of p53-mediated TranscriptionJournal of Biological Chemistry, 2008
- Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migrationNeurochemistry International, 2007
- Coordination of Cell Signaling, Chromatin Remodeling, Histone Modifications, and Regulator Recruitment in Human Matrix Metalloproteinase 9 Gene TranscriptionMolecular and Cellular Biology, 2004